AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Agouron Pharmaceuticals
Patient Assistance Program

Products covered:

Rescriptor (delavirdine)
Viracept (nelfinavir) 1-888-777-6637





Contact
Program Eligibility
The patient must meet the following criteria to qualify:
  • Has no health insurance or no prescription coverage.
  • Not eligible for Medicaid, ADAP, or other drug assistance programs.
  • Financial eligibility evaluated on a case-by-case basis.
Enrollment Process
Doctors or patients can call to enroll. Basic pre-screening questions are asked during the initial call. Once these questions are answered an application is sent to the doctor's office for completion.
Re-Application
Doctors must reapply every 3 months.
Comments
After the completed application has been received along with the original prescription, it can take several days for processing to be completed. The drug is delivered via 2-day Fed Ex.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network